Medical Bionic Implant and Artificial Organs Market Outlook (2023 to 2033)

Global medical bionic implant and artificial organs market demand is anticipated to be valued at US$ 30,469.1 million in 2023, forecast a CAGR of 8.8% to be valued at US$ 70,818.8 million from 2023 to 2033.

Growth is attributed to the growing economies, rising healthcare expenditures, and the introduction of new healthcare facilities. Organ transplantation becomes mandatory when an organ in the body of a person is damaged due to injury or disease. But, the number of organ donors is very less than the demand. Although after the organ is transplanted, there are chances of rejection of the transplanted organ.

This signifies that the immune system of the recipient is not able to accept the organ. Artificial organs and bionics are made of biomaterial. Biomaterial is a living or non-living substance that is introduced into the body as a portion of an artificial organ or bionics to substitute an organ or functions associated with it.

The heart and kidney are the most developed artificial organs, while pacemakers and cochlear implants are the most developed medical bionics.

Attributes Details
Medical Bionic Implant and Artificial Organs Market CAGR (2023 to 2033) 8.8%
Medical Bionic Implant and Artificial Organs Market Size (2023) US$ 30,469.1 million
Medical Bionic Implant and Artificial Organs Market Size (2033) US$ 70,818.8 million

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Growth of the Medical Bionic Implant and Artificial Organs Industry (2018 to 2022 vs. 2023 to 2033)

From 2018 to 2022, a CAGR of 8.1% was registered for the medical bionic implant and artificial organs sector. Market valuation expanded from US$ 19774.30 million in 2018 to US$ 27,753.3 million in 2022.

Artificial organs and medical bionic implants are increasingly in demand as bionics combines biology and electronics. Due to better research in some locations compared to others, the market for some bionic devices, such as exoskeletons, bionic orthopedics, and the bionic eye, is skewed in favor of those places.

Medical Bionics are a substitute or improvement of other body parts with robotic versions. Medical bionic implants are diverse from artificial organs, they impersonate the original function very thoroughly or even do better than it.

Which are Some Prominent Drivers Spearheading Medical Bionic Implant and Artificial Organs Market Growth?

The Growing Need for Organ Transplants to Drive the Growth of the Market

Some of the driving factors that propel the medical bionic implant and artificial organs business include age and age-related disorders, increasing accidents and injuries, and growth in the number of organ transplant cases. One of the key factors in the increase of visually impaired patients is the expanding aging population in the world.

Currently, the medical bionic implant and artificial organs global market is driven by the fact that a large number of patients are in need of organ transplantation, although not everyone gets an organ as the number of donors is less. Growing advancements in medical technologies are fueling the global market.

Growing public awareness about various diseases, advancements in medical bionic implant and artificial organs procedures, and the need for screenings conducted for early diagnosis and treatment of various diseases are also expected to favor the global medical bionic implant and artificial organs sector.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Challenges Faced by the Medical Bionic Implant and Artificial Organs Industry?

High Cost Associated with Implant Procedures Hinder the Growth of the Market

Although the medical bionic implant and artificial organs industry has numerous end-uses, there are numerous obstacles that likely pose a challenge to market growth. The high cost associated with organ transplant procedures, and the price of medical bionics, and the high cost of artificial organs, and the lengthy approval procedure, act as a restraint for a global market.

An artificial heart transplant result in death or crippling damage, which is projected to hinder the market growth. Also, the limited surgical professionals, reimbursement conditions in different regions, and stringent regulatory guidelines are the reasons restraining the growth of the medical bionic implant and artificial organs sector.

Regional Analysis

Countries Market Share (2022)
United States 26.2%
Germany 3.2%
Japan 2.2%

Why is North America Emerging as an Opportunistic Medical Bionic Implant and Artificial Organs Market?

Technological Advancement in the Region Boosts the Growth

North America dominated the global medical bionic implant and artificial organs sector in 2022. North America accounts for a market share of 31.2% in the global market. The growth of the market in the region is attributed to the increased adoption of modern technologies and the presence of numerous industry players in the region.

North America is the leading market for medical bionic implants and artificial organs due to investment in research and development and increased healthcare expenditures on artificial prostheses.

For instance, on July 21, United States surgeons successfully completed the first human implantation in the United States of an artificial heart device called the 'Aeson', developed by French company CARMAT.

How is Europe Contributing to the Growth of the Medical Bionic Implant and Artificial Organs Industry?

Technically Advanced Healthcare in Europe Boosts the Growth of the Market

According to Future Market Insights, Europe is expected to provide immense growth opportunities for medical bionic implants and artificial organs. Europe’s medical market accounts for 20.5% share of the total global industry. The increasing geriatric population across the region is projected to drive demand for medical bionic implants and artificial organs due to the increasing use of bionic prosthetic devices.

The growth of the market is attributed to continuous research and development investment, rising disposable income, the purchasing power of individuals, and well established healthcare infrastructure. The rising prevalence of renal disorders, acute renal failure, and the increase in organ failure due to the aging population are some more factors driving the market in this region.

With the increased approvals and releases of innovative medical bionic implants, Europe is also exhibiting substantial growth in the medical bionic implants and artificial organs market over the forecast period.

For instance, Advanced Bionics AG obtained approval from the Technical Inspection Authority (TÜV) in Munich, Germany, for the HiFocus SlimJ electrode, an electrode for the HiRes Ultra cochlear implant platform. During electrode insertion, the HiFocus SlimJ electrode preserves the cochlea.

Does the Asia Pacific emerge as an Attractive Medical Bionic Implant and Artificial Organs Market?

Countries Market CAGR (2023 to 2033)
China 9.6%
India 7.4%

Asia-Pacific is expected to grow at a significant rate due to a large consumer base, rising government initiatives for enhancing healthcare, and high disposable income contributing to the global market during the forecast period.

Also, medical tourism and the growing healthcare industry, advancements in implant techniques in the region are propelling the growth of the medical bionic implants and artificial organs market in the region.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Start-up Scenario

Medical Bionic Implant and Artificial Organs Start-ups are Moving Toward Collaboration

The new medical bionic implant and artificial organs market is continually indulging in several collaborations and highly investing in research and development activities to provide more convenient solutions to industry verticals. Key start-ups that are leading the development of the market are Aether Biomedical, Tissium, Bivacor, Advanced Prosthetic & Orthotic Centre, and Pixium Vision among others.

  • Advanced Prosthetic & Orthotic Centre - incorporated in the year 2009. The firm is engaged in diverse business activities, which include Manufacturer and Wholesaler wide range of Orthopedic Products used in various sectors. Some of our products include Knee Prosthesis, Prosthetic Foot, Hand Prosthesis etc
  • Pixium Vision, created in December 2011, is a bioelectronics and brain machine interface technology company specialized in neuromodulation application to create a world of bionic vision for those who have lost their sight, enabling them to regain partial visual perception and greater autonomy.

Market Competition

Competitors Push Boundaries for Strategic Maneuvers in the Industry

Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as Bionics Inc., Lifenet Health Inc., Cochlear Ltd., Sonova, Otto Bock Inc., and Edwards Lifesciences Corporation account for considerable market size, several regional-level players are also operating across key growth regions, particularly in the Asia Pacific.

  • In September 2022 -- Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards' breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve. The launch follows recent United States Food and Drug Administration (FDA) approval.
    • The MITRIS RESILIA valve, a tissue valve replacement created specifically for the heart's mitral location, received FDA clearance in March 2022, according to Edwards Lifesciences.
  • In April 2022- Cochlear, Limited, acquired Oticon Medical. As part of the transaction, Cochlear has committed to providing ongoing support for Oticon Medical’s base of more than 75,000 hearing implant recipients, which includes Cochlear and acoustic implants.
  • In May 2022 -- Medtronic plc announced that it has completed the acquisition of Intersect ENT, expanding the company's comprehensive ear, nose, and throat (ENT) portfolio with innovative products used in sinus procedures to improve post-operative outcomes and to treat nasal polyps.

Key Players

  • Touch Bionics Inc.
  • Lifenet Health Inc.
  • Cochlear Ltd.
  • Sonova
  • Otto Bock Inc.
  • Edwards Lifesciences Corporation
  • Medtronic, Inc.
  • HeartWare
  • Orthofix Holdings, Inc.
  • BionX Medical Technologies Inc.

Key Segments

By Product Type:

  • Heart Bionics
    • Ventricular Assist Device
    • Total Artificial Heart
    • Artificial Heart Valves
  • Pacemaker
    • Implantable Cardiac Pacemaker
    • External Pacemaker
  • Orthopedic Bionics
    • Bionic Hand
    • Bionic Limb
    • Bionic Leg
    • Ear Bionics
  • Bone Anchored Hearing Aid
  • Cochlear Implant

By Implant Location:

  • Externally Worn
  • Implantable Medical

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Frequently Asked Questions

What is the Potential of Growth in the Market?

The market is expected to maintain its momentum at an 8.8% CAGR through 2033.

What May the Market Size be in 2033?

The market is expected to be around US$ 70,818.8 million by 2033.

How Significant is the Market Size Presently?

In 2023, the market is expected to be about US$ 30,469.1 million.

What is the Market Share of Germany?

Germany is expected to gain 3.2% of the market by 2033.

What is the Market Share of the United States?

By 2033, the United States is expected to possess 26.2% of the market.

How the Market is Advancing in Japan?

Japan is expected to capture 2.2% of the market by 2033.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. Heart Bionics

            5.3.1.1. Ventricular Assist Device

            5.3.1.2. Total Artificial Heart

            5.3.1.3. Artificial Heart Valves

        5.3.2. Pacemaker

            5.3.2.1. Implantable Cardiac Pacemaker

            5.3.2.2. External Pacemaker

        5.3.3. Orthopedic Bionics

            5.3.3.1. Bionic Hand

            5.3.3.2. Bionic Limb

            5.3.3.3. Bionic Leg

            5.3.3.4. Ear Bionics

        5.3.4. Bone Anchored Hearing Aid

        5.3.5. Cochlear Implant

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Implant Location

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Implant Location, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Implant Location, 2023 to 2033

        6.3.1. Externally Worn Medical Bionic Implant and Artificial Organs

        6.3.2. Implantable Medical Bionic Implant and Artificial Organs

    6.4. Y-o-Y Growth Trend Analysis By Implant Location, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Implant Location, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Product Type

        8.2.3. By Implant Location

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product Type

        8.3.3. By Implant Location

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Product Type

        9.2.3. By Implant Location

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Implant Location

    9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Product Type

        10.2.3. By Implant Location

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Implant Location

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Product Type

        11.2.3. By Implant Location

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Implant Location

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Product Type

        12.2.3. By Implant Location

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Implant Location

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Product Type

        13.2.3. By Implant Location

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Implant Location

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Product Type

        14.2.3. By Implant Location

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Implant Location

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Product Type

            15.1.2.2. By Implant Location

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Product Type

            15.2.2.2. By Implant Location

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Product Type

            15.3.2.2. By Implant Location

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Product Type

            15.4.2.2. By Implant Location

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Product Type

            15.5.2.2. By Implant Location

    15.6. U.K.

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Product Type

            15.6.2.2. By Implant Location

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Product Type

            15.7.2.2. By Implant Location

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Product Type

            15.8.2.2. By Implant Location

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Product Type

            15.9.2.2. By Implant Location

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Product Type

            15.10.2.2. By Implant Location

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Product Type

            15.11.2.2. By Implant Location

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Product Type

            15.12.2.2. By Implant Location

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Product Type

            15.13.2.2. By Implant Location

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Product Type

            15.14.2.2. By Implant Location

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Product Type

            15.15.2.2. By Implant Location

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Product Type

            15.16.2.2. By Implant Location

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Product Type

            15.17.2.2. By Implant Location

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Product Type

            15.18.2.2. By Implant Location

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Product Type

            15.19.2.2. By Implant Location

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Product Type

            15.20.2.2. By Implant Location

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Product Type

            15.21.2.2. By Implant Location

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Product Type

            15.22.2.2. By Implant Location

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Product Type

            15.23.2.2. By Implant Location

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product Type

        16.3.3. By Implant Location

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Touch Bionics Inc.

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Lifenet Health Inc.

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Cochlear Ltd.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Sonova

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Otto Bock Inc.

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Edwards Lifesciences Corporation

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Medtronic, Inc.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. HeartWare

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. Orthofix Holdings, Inc.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. BionX Medical Technologies Inc.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

3D Bio-Printing Market

January 2024

REP-GB-808

321 pages

Healthcare

3D Printed Medical Implants Market

October 2022

REP-GB-6004

340 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Medical Bionic Implant And Artificial Organs Market

Schedule a Call